Atezolizumab
Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.
Product Specifications
CAS Number
1380723-44-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
145 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog